Evidence map›Paper›PMID 35185438›Full record

ArticleAmerican journal of lifestyle medicine

Scoring Lifestyle Medicine Goals With FIFA 2022-An Opportunity to Strike Big!

Sathyanarayanan Doraiswamy, Sohaila Cheema, Javaid I Sheikh, Ravinder Mamtani

Abstract read
In one paragraph

Article in American journal of lifestyle medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sathyanarayanan DoraiswamyInstitute for Population Health, Weill Cornell Medicine, Doha, Qatar (SD, SC, RM) and Weill Cornell Medicine, Doha, Qatar (JS).ORCID https://orcid.org/0000-0002-4198-8065
Sohaila CheemaInstitute for Population Health, Weill Cornell Medicine, Doha, Qatar (SD, SC, RM) and Weill Cornell Medicine, Doha, Qatar (JS).
Javaid I SheikhInstitute for Population Health, Weill Cornell Medicine, Doha, Qatar (SD, SC, RM) and Weill Cornell Medicine, Doha, Qatar (JS).
Ravinder MamtaniInstitute for Population Health, Weill Cornell Medicine, Doha, Qatar (SD, SC, RM) and Weill Cornell Medicine, Doha, Qatar (JS).

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Qatar is one of the few countries in the world with a dedicated national sports day. Qatar believes that sport is one of the best tools to promote a healthy lifestyle to help curb the growing burden of non-communicable diseases (NCDs). With the well-established positive health effects of soccer on cardiovascular, metabolic, and musculoskeletal conditions, the vision of the FIFA World Cup 2022™ hosted by Qatar to use the power of soccer to "open the door of an amazing world experience" is praiseworthy. With NCDs accounting for 70% of deaths in Qatar, there exists a perfect opportunity to promote healthy lifestyles to prevent, treat, and reverse NCDs. We believe that the FIFA World Cup 2022™ presents an opportunity that could contribute to generating valuable evidence on the lifestyle benefits of such large-scale events. This event comes at an opportune moment for countries in the region to make their health systems lifestyle-sensitive. FIFA World Cup 2022™ could just be the tipping point in the region that establishes the role of sports in mitigating the burden of NCDs. With the impact of COVID-19 on persons with pre-existing NCDs, the urgency for addressing the "syndemic" cannot be overemphasized and sport can be the lifestyle medicine.

Indexed as

health policynon-communicable diseasesphysical activitysoccerworld cup

Identifiers

PMID35185438
PMCPMC8848109

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.